 |
 |

Complications From Planned, Posttreatment Neck Dissections
Bruce J. Davidson, MD;
Kenneth A. Newkirk, MD;
K. William Harter, MD;
Catherine A. Picken, MD;
Kevin J. Cullen, MD;
Roy B. Sessions, MD
Arch Otolaryngol Head Neck Surg. 1999;125:401-405.
Objective To report the complication rate from planned, posttreatment neck dissections in patients who show control of primary squamous cell carcinoma by chemotherapy and radiotherapy or radiotherapy alone.
Design Retrospective review of case series.
Setting Georgetown University Medical Center, Washington, DC.
Patients Thirty-four patients with clinically positive neck disease treated with organ preservation therapy for squamous cell carcinoma of the head and neck.
Interventions Planned neck dissection after treatment with chemotherapy and radiotherapy or radiotherapy alone.
Main Outcome Measure Perioperative complications.
Results Forty-one neck dissections were performed on 34 patients. Complications were seen in 13 (38%) of 34 patients and 15 (37%) of 41 neck dissections. Wound complications occurred in 9 (22%) of 41 dissections. Neck dissection complication rate did not correlate with previous use of chemotherapy or with the use of brachytherapy at the primary site at the time of the neck dissection. Preoperative radiotherapy dose greater than 70 Gy was associated with complications in 58% vs 29% when preoperative dose was less than 70 Gy (P=.09). This trend was reflected primarily in wound complications (42% vs 14%; P=.10) and reached significance for skin flap necrosis (33% vs 0%; P=.005). Other factors that were associated with increased complications were preoperative albumin level less than 38 g/L and early neck drain removal.
Conclusions The complication rate associated with planned posttreatment neck dissection is similar to that previously reported for neck dissection. Wound complications are more common when higher preoperative radiotherapy doses are used.
From the Departments of OtolaryngologyHead and Neck Surgery (Drs Davidson, Newkirk, Picken, and Sessions) and Radiation Medicine (Dr Harter), and the Division of Hematology/Oncology (Dr Cullen), Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC. Dr Sessions is now with the Department of OtolaryngologyHead and Neck Surgery, Beth Israel Medical Center, New York, NY.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Surgical Wound Complications After Intensive Chemoradiotherapy for Advanced Squamous Cell Carcinoma of the Head and Neck
Morgan et al.
Arch Otolaryngol Head Neck Surg 2007;133:10-14.
ABSTRACT
| FULL TEXT
Effectiveness of Superselective and Selective Neck Dissection for Advanced Nodal Metastases After Chemoradiation
Robbins et al.
Arch Otolaryngol Head Neck Surg 2005;131:965-969.
ABSTRACT
| FULL TEXT
The Role of Cervical Lymphadenectomy After Aggressive Concomitant Chemoradiotherapy: The Feasibility of Selective Neck Dissection
Stenson et al.
Arch Otolaryngol Head Neck Surg 2000;126:950-956.
ABSTRACT
| FULL TEXT
|